Open in a separate window The use of nebulizable, nanoparticle-based antimicrobial

Open in a separate window The use of nebulizable, nanoparticle-based antimicrobial delivery systems can improve efficacy and reduce toxicity for treatment of multi-drug-resistant bacteria in the chronically infected lungs of cystic fibrosis patients. cations and core SCC10. All three formulations provided a sustained delivery of silver over the course of at least 2C4 days. The… Continue reading Open in a separate window The use of nebulizable, nanoparticle-based antimicrobial